AIM2 and experimental autoimmune encephalomyelitis: Several studies have shown that Aim2 restrains clinical symptoms in experimental autoimmune encephalomyelitis (EAE) mice by stabilising T regulatory (Treg) cells,12, 14 suggesting that inflammasome‐independent Aim2 participates in the regulation of the CD4+ T‐cell response in autoimmune models.